Interestingly, higher TXNIP expression levels in On-treatment specimens positively correlated with higher degree of tumor regression (RECIST, Response Evaluation Criteria in Solid Tumors; linear model, P = 0.00898; Fig. 2E). Here, TXNIP is linked to neoplasm.